The Evaluation and Optimal Use of Rituximab in Lymphoid Malignancies

Blood and Lymphatic Cancer: Targets and Therapy
doi 10.2147/blctt.s15561
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search